Tēnā koutou
The Ministry is preparing for the 2020/21 MPDS round, for which a launch date has not yet been set. Māori Health Providers will be notified upon confirmation of this date.
Providers who hold current contracts for MPDS 2019/20 (extended to 31 December 2020 because of...More
The National Ethics Advisory Committee (NEAC) is an independent advisor to the Minister of Health. NEAC was established in 2001 by section 16 of the New Zealand Public Health and Disability Act 2000.
The National Ethics Advisory Committee’s statutory functions are to: ...More
Kia ora!
The Ministry of Health is participating in global research for the World Health Organization (WHO).
We are working to define what information people need in a pandemic by asking what topics are important to you.
The results are anonymous and may be used by governments...More
The Cancer Control Agency, in partnership with the Head and Neck Cancer Working Group, have developed a set of proposed quality performance indicators (QPIs) for Head and Neck Cancer.
A set of 14 QPIs have been selected, in partnership with sector leaders, to measure performance and drive...More
You are invited to review and provide comment on the draft HISO 10038.4 Cancer Multidisciplinary Meeting Data Standard.
Draft Cancer Multidisciplinary Meeting Data Standard (Word, 1.7 MB)
Draft Cancer Multidisciplinary Meeting Data Standard (PDF, 1.0 MB)
The draft...More
The Kia Kaha, Kia Māia, Kia Ora Aotearoa - COVID-19 psychosocial and mental wellbeing recovery plan provides a national approach to supporting the mental and social wellbeing of New Zealanders in the COVID-19 recovery period.
View the plan
Kia Kaha, Kia Māia, Kia Ora Aotearoa:...More
The Ministry of Health is currently seeking feedback on draft Terms of Reference and core standards for performance reviews of responsible authorities. (See the Ministry of Health website for more information about responsible authorities.)
When the Health Practitioners...More
Condoms and other contraceptive devices supplied in New Zealand are required to meet a gazetted standard. Section 6 of the Contraception, Sterilisation and Abortion Act 1977 grants the Minister of Health the power to approve Standards for condoms or other contraceptive devices by notice in the...More
The Ministry of Health is currently seeking feedback on proposed draft revisions to the Guidelines for the Mental Health (Compulsory Assessment and Treatment) Act 1992. These Guidelines are intended to assist providers and statutory officials in their application of the legislation, however they...More
Health care professionals need digital literacy to do their work safely and effectively. While other aspects of the health profession use traditional education models, we don’t currently have a formal training system or recognised titles for digital qualifications. People often work in digital...More
Medsafe is seeking comments on proposed changes to current warning and advisory statements for paracetamol.
At the December 2018 Medicines Adverse Reactions Committee (MARC) meeting, the Committee discussed a serious case report of acute liver failure in a young patient due to a...More
Tēnā koutou katoa
We are seeking your clinical review of proposed colorectal systemic anti-cancer therapy (chemotherapy) regimen definitions.
The Ministry and the Systemic Anti-Cancer Therapy (SACT) NZ Colorectal Work Group have developed a set of regimen definitions for colorectal...More
We believe that how we work together within the Ministry and with the health and disability sector, public service and communities is key to achieving pae ora – healthy futures for all New Zealanders.
We are working with our people to co-create new values to underpin the Ministry...More
Healthy Active Learning is a new Wellbeing Budget initiative that will promote and improve healthy eating and physical activity in schools, kura, ngā kōhanga reo and early learning services across Aotearoa.
The Ministry of Health (the Ministry) is currently drafting the...More
This document sets out possible wording for a new code of practice to be issued under the Radiation Safety Act 2016 for the use of non-medical irradiators. Section 86(2) of the Act requires that anyone likely to be affected by the code is consulted before it is issued. The purpose of this...More
This document sets out possible wording for a new code of practice to be issued under the Radiation Safety Act 2016 for the use of irradiating apparatus and radioactive material for veterinary diagnosis, research or therapy purposes. Section 86(2) of the Act requires that anyone likely to be...More
This document sets out possible wording for a new code of practice to be issued under the Radiation Safety Act 2016 for the use of unsealed radioactive material for non-medical purposes. Section 86(2) of the Act requires that anyone likely to be affected by the code is consulted before it is...More
This document sets out possible wording for a new code of practice to be issued under the Radiation Safety Act 2016 for the use of sealed radioactive material for non-medical purposes. Section 86(2) of the Act requires that anyone likely to be affected by the code is consulted before it is...More
This document sets out possible wording for a new code of practice to be issued under the Radiation Safety Act 2016 for the use of non-medical irradiating apparatus. Section 86(2) of the Act requires that anyone likely to be affected by the code is consulted before it is issued. The purpose of...More
66 people are told they have cancer every day.
Most New Zealanders will be impacted by cancer in their lifetime – either directly, or through friends or family members affected by cancer.
Right now, we are finalising the New Zealand Cancer Action Plan 2019-2029.
We want to hear...More
Tēnā koutou katoa,
We are seeking your feedback on the New Zealand Cancer Action Plan 2019–2029 (PDF, 1.5 MB) (the Plan).
The Ministry of Health has engaged with a number of cancer-sector stakeholders in the development of the Plan.
The following questions about the...More
To provide high quality maternity care in New Zealand we need to underpin maternity practice with information that supports the care of women, babies and their family/whānau, continuity of care, best practice, and analytics.
The HISO 10050.2:2019 Maternity Care Summary Standard is designed...More
Riluzole is a glutamate agonist used in the management of amyotrophic lateral sclerosis (ALS).
Riluzole is a prescription medicine approved under section 23 of the Medicines Act 1981. The following condition regarding prescriber access to this medicine applies.
More
The Government has committed to establishing a Medicinal Cannabis Scheme to improve access to quality medicinal cannabis products through:
enabling the commercial cultivation of medicinal cannabis and the manufacture of medicinal cannabis products in New Zealand
setting...More
The Radiation Safety Act 2016 came fully into force on 7 March 2017. The Act is administered by the Ministry of Health’s Office of Radiation Safety.
The Act sets out high-level safety and security obligations in sections 9–12. There are many different types of radiation use and the...More
The Ministry and the National Lung Cancer Working Group (the Working Group) have worked together to develop a set of proposed quality performance indicators (QPIs) for lung cancer.
The proposed indicators have been selected to measure performance and drive quality improvement in lung...More
Consultation overview:
The Well Child Tamariki Ora Programme (WCTO) provides universal child health services and checks to tamariki and their whānau. It is a key contributor to the Government’s cross-agency work to improve child Wellbeing, and is a priority within the government to...More
This Medsafe consultation proposes labelling requirements for substances/groups of substances in medicines and related products that may cause an undesirable reaction (eg, allergies) in some people.
Unlike foods, most medicines and related products are not required to list all the...More